Cardiac effects of lead

Area of Science:

• Toxicology
• Cardiovascular Science
• Neuroscience

Background:

• Lead (Pb) intoxication is associated with cardiac disease symptoms.
• Cardiotoxicity from lead exposure has been observed in both humans and experimental animals.
• Observed cardiac effects include negative inotropism and electrocardiogram abnormalities, such as conduction defects.

Purpose of the Study:

• To investigate the cardiotoxic effects of lead exposure, particularly focusing on arrhythmogenic responses.
• To determine if early-life lead exposure influences sensitivity to adrenergic agents in adulthood.
• To explore the mechanisms underlying lead-induced cardiotoxicity and arrhythmogenesis.

Main Methods:

• Neonatal rats were exposed to lead acetate via maternal milk.
• Adult rats exposed neonatally were assessed for sensitivity to the arrhythmogenic effects of norepinephrine (NE) in vivo and in vitro.
• Studies included in vivo and isolated heart preparations.
• Pharmacological interventions (atropine, vagotomy) were used to investigate neural involvement.

Main Results:

• Neonatal lead exposure resulted in a fourfold increase in sensitivity to the arrhythmogenic effect of norepinephrine in adult rats compared to controls.
• Cardiotoxicity was observed after exposure as early as the first 10 postnatal days, manifesting in adulthood.
• Increased sensitivity to NE-induced arrhythmogenesis was confirmed both in vivo and in isolated hearts.
• Vagal nerve involvement in norepinephrine arrhythmogenesis was suggested by attenuation with atropine or vagotomy.

Conclusions:

• Early-life lead exposure can induce long-lasting cardiotoxicity and heightened sensitivity to adrenergic stimulation.
• The findings highlight the vulnerability of the developing cardiovascular system to lead.
• Potential mechanisms involve central GABAergic systems, adrenergic nerve development, and lead-calcium interactions.